help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 68, No. 6 1101-1105
doi:10.1210/jcem-68-6-1101
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSENTHAL, S. M.
Right arrow Articles by GRUMBACH, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSENTHAL, S. M.
Right arrow Articles by GRUMBACH, M. M.

Short Term Continuous Intravenous Infusion of Growth Hormone (GH) Inhibits GH-Releasing Hormone-Induced GH Secretion: A Time-Dependent Effect*

STEPHEN M. ROSENTHAL, SELNA L. KAPLAN and MELVIN M. GRUMBACH

Department of Pediatrics, University of California San Francisco, California 94143

Address requests for reprints to: Stephen M. Rosenthal, M.D., Box 0434, University of California, San Francisco, California 94143.

We previously reported that GH secretion evoked by GHRH is inhibited after 5 days of treatment with im GH. This impaired pituitary response was associated with a significant increase in the serum concentration of insulin-like growth factor I (IGF-I). To dissociate the possible effects of circulating IGF-I from other effects of GH on the pituitary response to GHRH, we carried out the following study in eight normal men. A bolus injection of GHRH (1 µg/kg, iv) was administered 2 h after the start of a 4-h continuous iv infusion of GH (180-µg bolus dose, then 3 µg/min in 150 mmol/L NaCl) or placebo (150 mmol/L NaCl). In addition, a similar injection of GHRH was given 4 h after the start of a 6-h continuous iv GH infusion (180-µg bolus dose, then 3 µg/min). During the GH infusions, plasma GH levels reached steady state concentrations in the 9–13 µg/L range. The mean GHRH-induced GH response was not significantly blunted during the 4-h infusions of GH 724 ± 163 (±SE) vs. 1184 ± 373 µg·min/L during placebo; P = 0.29], but was significantly inhibited during the 6-h GH infusions 226 ± 105 µg·min/L; P = 0.04 vs. control). Serum IGF-I or plasma glucose did not change significantly throughout the GH infusions. During the 6-h GH infusions, plasma FFA increased to levels significantly above basal values during the last 3 h of the 6-h infusion. These results indicate that short term GH infusion inhibits the plasma GH response to GHRH in a timedependent manner. The inhibition is not due to changes in circulating IGF-I and glucose concentrations. Fluctuations in hypothalamic somatostatin secretion, changes in lipid or other GH-dependent metabolites, paracrine effects of IGF-I, or a direct effect of GH itself may cause the impaired pituitary responsiveness during short term iv GH infusion.

* This work was supported in part by a grant from the NICHHD, NIH (R01-HD-02335), and the NIH, Pediatric Clinical Research Center (RR-01271). Presented in part at the 68th Annual Meeting of The Endocrine Society, Anaheim, CA, 1986.

Received August 25, 1988.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Veldhuis, S. A. Hudson, J. N. Bailey, and D. Erickson
Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E483 - E489.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, L. Farhy, A. L. Weltman, J. Kuipers, J. Weltman, and L. Wideman
Gender Modulates Sequential Suppression and Recovery of Pulsatile Growth Hormone Secretion by Physiological Feedback Signals in Young Adults
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2874 - 2881.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Hashimoto, T. Kamioka, M. Hosaka, K. Mabuchi, A. Mizuchi, Y. Shimazaki, M. Tsunoo, and T. Tanaka
Exogenous 20K Growth Hormone (GH) Suppresses Endogenous 22K GH Secretion in Normal Men
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 601 - 606.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Wilson
Effects of Estradiol and Exogenous Insulin-Like Growth Factor I (IGF-I) on the IGF-I Axis during Growth Hormone Inhibition and Antagonism
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4013 - 4021.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Wilson
Regulation of the Growth Hormone-Insulin-Like Growth Factor I Axis in Developing and Adult Monkeys Is Affected by Estradiol Replacement and Supplementation with Insulin-Like Growth Factor I
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2018 - 2028.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
V. Chandrashekar and A. Bartke
The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats
Endocrinology, March 1, 1998; 139(3): 1067 - 1074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society